Fatma Nalan Cetin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fatma Nalan Cetin has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Kristyna Kolouchova
Polymer Chemistry and Biomaterials Group Centre of Macromolecular Chemistry Department of Organic and Macromolecular Chemistry Ghent University Ghent Belgium
2 shared publications - Arn Mignon
Smart Polymeric Biomaterials, Campus Group T, KU Leuven, 3000 Leuven, Belgium
1 shared publication Filip Koucký
Department of Inorganic Chemistry Faculty of Science Charles University Prague Czech Republic
1 shared publicationJiří Beneš
Institute of Biophysics and Informatics First Faculty of Medicine Charles University Prague Czech Republic
1 shared publication- Klara Steklikova
Institute of Histology and Embryology, First Faculty of Medicine, Charles University, Prague, Czech Republic
1 shared publication Linda Dalecká
Institute of Histology and Embryology First Faculty of Medicine Charles University Prague Czech Republic
1 shared publication
Latest Publications
- Open Access
- 13 September 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (37) , e71667
Hydrophilic Polymers Enable Gastrointestinal Transit Monitoring by Fluorine‐19 Magnetic Resonance Imaging
Gastrointestinal (GI) transit shapes nutrient absorption and oral drug delivery. However, GI anatomy, function, and motility disorders are primarily examined by radiographic imaging, which exposes patients to ionizing radiation and yields only coarse proxies of how a meal moves through the gut. By contrast, fluorine‐19 ( 19 F) MRI offers background‐free, quantitative tracking, but most oral 19 F agents are hydrophobic and phase‐separate from chyme, generating layering artifacts, which spoil motility and anatomy readouts. Here, we developed nonresorbable, hydrophilic fluorinated polymer tracers miscible with luminal contents. These tracers provided a strong, quantifiable 19 F signal for combined 1 H/ 19 F MRI and 19 F spectroscopy, enabling us to visualize GI anatomy and transit noninvasively. In vivo imaging reliably tracked whole‐gut transit and fecal elimination, with no evidence of systemic uptake or tissue injury. As such, this practical, reproducible, and radiation‐free platform for phenotyping dysmotility and monitoring therapeutic response may open up opportunities for longitudinal GI studies and clinical trials.
- 13 September 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (37) , e71667
Open AccessHydrophilic Polymers Enable Gastrointestinal Transit Monitoring by Fluorine‐19 Magnetic Resonance Imaging
Gastrointestinal (GI) transit shapes nutrient absorption and oral drug delivery. However, GI anatomy, function, and motility disorders are primarily examined by radiographic imaging, which exposes patients to ionizing radiation and yields only coarse proxies of how a meal moves through the gut. By contrast, fluorine‐19 ( 19 F) MRI offers background‐free, quantitative tracking, but most oral 19 F agents are hydrophobic and phase‐separate from chyme, generating layering artifacts, which spoil motility and anatomy readouts. Here, we developed nonresorbable, hydrophilic fluorinated polymer tracers miscible with luminal contents. These tracers provided a strong, quantifiable 19 F signal for combined 1 H/ 19 F MRI and 19 F spectroscopy, enabling us to visualize GI anatomy and transit noninvasively. In vivo imaging reliably tracked whole‐gut transit and fecal elimination, with no evidence of systemic uptake or tissue injury. As such, this practical, reproducible, and radiation‐free platform for phenotyping dysmotility and monitoring therapeutic response may open up opportunities for longitudinal GI studies and clinical trials.
- 14 November 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (1) , e2402699
Polymer‐ and Lipid‐Based Nanostructures Serving Wound Healing Applications: A Review
Management of hard‐to‐heal wounds often requires specialized care that surpasses the capabilities of conventional treatments. Even the most advanced commercial products lack the functionality to meet the needs of hard‐to‐heal wounds, especially those complicated by active infection, extreme bleeding, and chronic inflammation. The review explores how supramolecular nanovesicles and nanoparticles—such as dendrimers, micelles, polymersomes, and lipid‐based nanocarriers—can be key to introducing advanced wound healing and monitoring properties to address the complex needs of hard‐to‐heal wounds. Their potential to enable advanced functions essential for next‐generation wound healing products—such as hemostatic functions, transdermal penetration, macrophage polarization, targeted delivery, and controlled release of active pharmaceutical ingredients (antibiotics, gaseous products, anti‐inflammatory drugs, growth factors)—is discussed via an extensive overview of the recent reports. These studies highlight that the integration of supramolecular systems in wound care is crucial for advancing toward a new generation of wound healing products and addressing significant gaps in current wound management practices. Current strategies and potential improvements regarding personalized therapies, transdermal delivery, and the promising critically evaluated but underexplored polymer‐based nanovesicles, including polymersomes and proteinosomes, for wound healing.
- 14 November 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (1) , e2402699
Polymer‐ and Lipid‐Based Nanostructures Serving Wound Healing Applications: A Review
Management of hard‐to‐heal wounds often requires specialized care that surpasses the capabilities of conventional treatments. Even the most advanced commercial products lack the functionality to meet the needs of hard‐to‐heal wounds, especially those complicated by active infection, extreme bleeding, and chronic inflammation. The review explores how supramolecular nanovesicles and nanoparticles—such as dendrimers, micelles, polymersomes, and lipid‐based nanocarriers—can be key to introducing advanced wound healing and monitoring properties to address the complex needs of hard‐to‐heal wounds. Their potential to enable advanced functions essential for next‐generation wound healing products—such as hemostatic functions, transdermal penetration, macrophage polarization, targeted delivery, and controlled release of active pharmaceutical ingredients (antibiotics, gaseous products, anti‐inflammatory drugs, growth factors)—is discussed via an extensive overview of the recent reports. These studies highlight that the integration of supramolecular systems in wound care is crucial for advancing toward a new generation of wound healing products and addressing significant gaps in current wound management practices. Current strategies and potential improvements regarding personalized therapies, transdermal delivery, and the promising critically evaluated but underexplored polymer‐based nanovesicles, including polymersomes and proteinosomes, for wound healing.